Determination That CARAFATE (Sucralfate) Oral Suspension, 1 Gram/10 Milliliters, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness

The Food and Drug Administration (FDA, Agency, or we) has determined that CARAFATE (sucralfate) oral suspension, 1 gram (g)/10 milliliters (mL), was not withdrawn from sale for reasons of safety or effectiveness. This determination means that FDA will not begin procedures to withdraw approval of abbreviated new drug applications (ANDAs) that refer to this drug product, and it will allow FDA to continue to approve ANDAs that refer to the product as long as they meet relevant legal and regulatory requirements.

created_at
provider_category
Notice
created_by
scheduled-job:a5bbbe5ddcbdd49aeae94c04e3e1fefe5._scheduled_job.98281506-8306-45a9-b190-5e32261f7ddd
providers
federal_register
text_url
https://www.federalregister.gov/documents/full_text/text/2026/09/02/2026-17968.txt
themes
government, policy, regulation
source
Federal Register
source_slug
federal-register
provider_count
1
url
https://www.federalregister.gov/documents/2026/09/02/2026-17968/determination-that-carafate-sucralfate-oral-suspension-1-gram10-milliliters-was-not-withdrawn-from
country
United States
language
English
org_id
0ac7c1ae-d6eb-4868-9eb4-96b085d4f7ba
dedup_key
0bca3474b5ce45285a704b454c16fdba623ea35a53424b32ff39b83fca9221e0
last_modified_at
provider
federal_register
feed_section
Government
last_modified_by
scheduled-job:a5bbbe5ddcbdd49aeae94c04e3e1fefe5._scheduled_job.98281506-8306-45a9-b190-5e32261f7ddd
published_at

Related